Taiwan Semiconductor Manufacturing Company Limited - 2330.TW

2330.TW Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2330.TW	1.4	0.9	3.2	3.2	11.4	90.5	69.2	236.3	705.8	26888.0
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare 2330.TW with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2330.TW
name	Taiwan Semiconductor Manufacturing Company Limited
price	1120
changes percentage	1.3575
change	15
day low	1095
day high	1125
year high	1160
year low	614
market cap	29040985120000
price avg 50	1063.12
price avg 200	960.28
exchange	TAI
volume	60289321
avg volume	36558888
open	1125
previous close	1105
eps	40.55
pe	27.62
earnings announcement	2025-04-16T10:59:00.000+0000
shares outstanding	25929451000
timestamp	2025-01-17 05:30:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 35.7%

Overall Quarterly Financial Health: 69.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2161735841000	2263891292000	-4.51
gross profit	1175110628000	1348354806000	-12.85
gross profit ratio	0.54	0.6	-8.73
research and development expenses	182370170000	163262208000	11.70
operating expenses	253645000000	227075955000	11.70
interest income	60293900000	22422209000	168.90
interest expense	11999400000	11749984000	2.12
ebitda	1518706507000	1585396616000	-4.21
ebitdaratio	0.7	0.7	0.04
operating income	921465600000	1121278851000	-17.82
operating income ratio	0.43	0.5	-13.94
net income	851740000000	992923400000	-14.22
net income ratio	0.39	0.44	-10.17
eps	32.85	39.2	-16.20

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2,161,736 million in 2023 from 2,263,891 million in 2022 representing a change of -4.51%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 1,175,111 million in 2023 from 1,348,355 million in 2022 representing a change of -12.85%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 253,645 million in 2023 from 227,076 million in 2022 representing a change of 11.7%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,518,707 million in 2023 from 1,585,397 million in 2022 representing a change of -4.21%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 851,740 million in 2023 from 992,923 million in 2022 representing a change of -14.22%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 32.85 in 2023 from 32.85 in 2022 representing a change of -16.2%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 182,370 million in 2023 from 163,262 million in 2022 representing a change of 11.7%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 921,466 million in 2023 from 1,121,279 million in 2022 representing a change of -17.82%. The increase in operating income indicates better operational performance and increased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	759692000000	673510177000	12.80
gross profit	439345000000	348453771000	26.08
gross profit ratio	0.58	0.52	11.78
research and development expenses	52783000000	48057704000	9.83
operating expenses	79078000000	60632891000	30.42
interest income	19966000000	20979233000	-4.83
interest expense	0	2638140000	-100.00
ebitda	360766000000	452987474000	-20.36
ebitdaratio	0.47	0.67	-29.39
operating income	360267000000	287820880000	25.17
operating income ratio	0.47	0.43	10.97
net income	325258000000	247845000000	31.23
net income ratio	0.43	0.37	16.35
eps	12.54	9.56	31.17

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 759,692 million in 2024Q3 from 673,510 million in 2024Q2 representing a change of 12.8%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 439,345 million in 2024Q3 from 348,454 million in 2024Q2 representing a change of 26.08%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 52,783 million in 2024Q3 from 48,058 million in 2024Q2 representing a change of 9.83%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 360,267 million in 2024Q3 from 287,821 million in 2024Q2 representing a change of 25.17%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 325,258 million in 2024Q3 from 247,845 million in 2024Q2 representing a change of 31.23%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 12.54 in 2024Q3 from 12.54 in 2024Q2 representing a change of 31.17%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 79,078 million in 2024Q3 from 60,633 million in 2024Q2 representing a change of 30.42%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 360,766 million in 2024Q3 from 452,987 million in 2024Q2 representing a change of -20.36%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	5532371215000	4964778878000	11.43
total liabilities	2049108368000	2004290011000	2.24
total equity	3483262847000	2960488867000	17.66
cash and cash equivalents	1465427753000	1342814083000	9.13
short term investments	222340989000	243686042000	-8.76
long term investments	129442117000	68927920000	87.79
total current assets	2194032910000	2052896744000	6.87
total non current assets	3338338305000	2911882134000	14.65
total current liabilities	913583316000	944226817000	-3.25
total non current liabilities	1135525052000	1060063194000	7.12
common stock	259320710000	259303805000	0.01
retained earnings	3158030792000	2637524688000	19.73
total debt	959068460000	888174472000	7.98

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 5,532,371 million in 2023 from 4,964,779 million in 2022 representing a change of 11.43%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 3,483,263 million in 2023 from 2,960,489 million in 2022 representing a change of 17.66%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,465,428 million in 2023 from 1,342,814 million in 2022 representing a change of 9.13%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 2,194,033 million in 2023 from 2,052,897 million in 2022 representing a change of 6.87%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 913,583 million in 2023 from 944,227 million in 2022 representing a change of -3.25%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 259,321 in 2023 from 259,304 in 2022 representing a change of 0.01%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,158,031 million in 2023 from 2,637,525 million in 2022 representing a change of 19.73%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,049,108 million in 2023 from 2,004,290 million in 2022 representing a change of 2.24%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 222,341 million in 2023 from 243,686 million in 2022 representing a change of -8.76%. This indicates a decrease in short-term investment holdings.

  Total Debt: Total Debt increased to 959,068 million in 2023 from 888,174 million in 2022 representing a change of 7.98%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	6165660000000	5982364014000	3.06
total liabilities	2143740000000	2162215809000	-0.85
total equity	4025077669000	3820148205000	5.36
cash and cash equivalents	1886781000000	1799127351000	4.87
short term investments	280819000000	249392491000	12.60
long term investments	127330000000	140219465000	-9.19
total current assets	2710450000000	2591658093000	4.58
total non current assets	3198930000000	3390705921000	-5.66
total current liabilities	1080400000000	1048915679999	3.00
total non current liabilities	1063340000000	1113300129001	-4.49
common stock	259327000000	259336292000	-0.00
retained earnings	3346232000000	3438674715000	-2.69
total debt	936160000000	997422613000	-6.14

Overall Score of Quarterly Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,165,660 million in 2024Q3 from 5,982,364 million in 2024Q2 representing a change of 3.06%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 2,143,740 million in 2024Q3 from 2,162,216 million in 2024Q2 representing a change of -0.85%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 4,025,078 million in 2024Q3 from 3,820,148 million in 2024Q2 representing a change of 5.36%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,886,781 million in 2024Q3 from 1,799,127 million in 2024Q2 representing a change of 4.87%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 280,819 million in 2024Q3 from 249,392 million in 2024Q2 representing a change of 12.6%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 2,710,450 million in 2024Q3 from 2,591,658 million in 2024Q2 representing a change of 4.58%. This indicates a better liquidity position.

  Total Debt: Total Debt decreased to 936,160 million in 2024Q3 from 997,423 million in 2024Q2 representing a change of -6.14%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Liabilities: Total Current Liabilities increased to 1,080,400 million in 2024Q3 from 1,048,916 million in 2024Q2 representing a change of 3.0%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 259,327 in 2024Q3 from 259,336 in 2024Q2 representing a change of -0.0%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 3,346,232 million in 2024Q3 from 3,438,675 million in 2024Q2 representing a change of -2.69%. This indicates an accumulated losses.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	122613670000	277823891000	-55.87
operating cash flow	1241967300000	1610599188000	-22.89
free cash flow	286568900000	520972732000	-44.99
capital expenditure	-955398400000	-1089626456000	12.32
depreciation and amortization	532190921000	437254273000	21.71
deferred income tax	0	0	NaN
stock based compensation	544379000	302400000	80.02
accounts payables	770712000	7594105000	-89.85
inventory	-29847940000	-28046827000	-6.42
acquisitions net	11752685000	17246906000	-31.86
investments in property plant and equipment	-949816825000	-1089626456000	12.83
net cash used for investing activites	-906120600000	-1190928235000	23.91
debt repayment	93347400000	82008600000	13.83
common stock issued	0	0	NaN
common stock repurchased	0	-871566000	100.00
dividends paid	-291721852000	-285234185000	-2.27
net cash used provided by financing activities	-204894200000	-200244032000	-2.32
cash at end of period	1465427753000	1342814083000	9.13
accounts receivables	29398598000	-32169900000	191.39
cash at beginning of period	1342814083000	1064990192000	26.09

Overall Score of Annual Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 122,614 million in 2023 from 277,824 million in 2022 representing a change of -55.87%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 1,241,967 million in 2023 from 1,610,599 million in 2022 representing a change of -22.89%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 286,569 million in 2023 from 520,973 million in 2022 representing a change of -44.99%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -955,398 million in 2023 from -1,089,626 million in 2022 representing a change of 12.32%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 544 million in 2023 from 302 million in 2022 representing a change of 80.02%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 29,399 in 2023 from -32,170 million in 2022 representing a change of 191.39%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -291,722 million in 2023 from -285,234 million in 2022 representing a change of -2.27%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Payables: The absolute value of Accounts Payables decreased to 771 million in 2023 from 7,594 million in 2022 representing a change of -89.85%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	412449622000	377668210000	9.21
free cash flow	197442888000	171993526000	14.80
capital expenditure	-215006734000	-205674684000	-4.54
depreciation and amortization	168229000000	165166594000	1.85
deferred income tax	0	0	NaN
stock based compensation	0	348564000	-100.00
accounts receivables	0	-7620441000	100.00
accounts payables	0	6337064000	-100.00
inventory	0	-5367248000	100.00
acquisitions net	-6391670000	-26114000	-24376.03
investments in property plant and equipment	-215006734000	-205674684000	-4.54
net cash used for investing activites	-225808068000	-197607330000	-14.27
debt repayment	11245707000	10259235000	9.62
common stock issued	0	0	NaN
common stock repurchased	177000	-3089177000	100.01
dividends paid	-90762539000	-90762248000	-0.00
net cash used provided by financing activities	-72715563000	-90244583000	19.42
net change in cash	87653649000	100931647000	-13.16
cash at end of period	1886781000000	1799127351000	4.87
cash at beginning of period	1799127351000	1698195704000	5.94

Overall Score of Quarterly Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 87,654 million in 2024Q3 from 100,932 million in 2024Q2 representing a change of -13.16%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q3 from -7,620 million in 2024Q2 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -90,763 million in 2024Q3 from -90,762 million in 2024Q2 representing a change of -0.0%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 412,450 million in 2024Q3 from 377,668 million in 2024Q2 representing a change of 9.21%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 197,443 million in 2024Q3 from 171,994 million in 2024Q2 representing a change of 14.8%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -215,007 million in 2024Q3 from -205,675 million in 2024Q2 representing a change of -4.54%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 349 million in 2024Q2 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 6,337 million in 2024Q2 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	83.37	87.31	-4.51
net income per share	32.85	38.29	-14.22
operating cash flow per share	47.9	62.12	-22.89
free cash flow per share	11.05	20.09	-44.99
cash per share	65.09	61.19	6.38
book value per share	134.34	114.18	17.66
tangible book value per share	133.46	113.17	17.92
shareholders equity per share	133.4	113.6	17.42
interest debt per share	37.45	34.71	7.91
market cap	15376015600000	11629241715000	32.22
enterprise value	14869656307000	11174602104000	33.07
pe ratio	18.05	11.71	54.13
price to sales ratio	7.11	5.14	38.47
pocfratio	12.38	7.22	71.46
pfcf ratio	53.66	22.32	140.37
pb ratio	4.45	3.95	12.60
ptb ratio	4.45	3.95	12.60
ev to sales	6.88	4.94	39.35
enterprise value over ebitda	9.79	7.05	38.91
ev to operating cash flow	11.97	6.94	72.56
ev to free cash flow	51.89	21.45	141.91
earnings yield	0.06	0.09	-35.12
free cash flow yield	0.02	0.04	-58.40
debt to equity	0.28	0.3	-8.04
debt to assets	0.17	0.18	-3.10
net debt to ebitda	-0.33	-0.29	-16.27
current ratio	2.4	2.17	10.46
interest coverage	76.79	95.43	-19.53
income quality	1.48	1.41	5.23
dividend yield	0.02	0.02	-22.65
payout ratio	0.34	0.29	19.23
sales general and administrative to revenue	0.03	0.02	19.10
research and ddevelopement to revenue	0.08	0.07	16.98
intangibles to total assets	0.0	0.01	-21.42
capex to operating cash flow	0.77	0.68	13.71
capex to revenue	0.44	0.48	-8.18
capex to depreciation	1.8	2.49	-27.96
stock based compensation to revenue	0.0	0.0	88.53
graham number	314.0	312.86	0.36
roic	0.17	0.3	-43.97
return on tangible assets	0.15	0.2	-23.11
graham net net	-3.25	-5.15	36.90
working capital	1280449594000	1108669927000	15.49
tangible asset value	3460496103000	2934489712000	17.92
net current asset value	144924542000	48606733000	198.16
invested capital	4408116152000	3870420188000	13.89
average receivables	216709510000	214885892000	0.85
average payables	162836178500	230703550000	-29.42
average inventory	236073118000	207125734500	13.98
days sales outstanding	34.11	37.31	-8.58
days payables outstanding	21.2	107.0	-80.19
days of inventory on hand	92.86	88.17	5.32
receivables turnover	10.7	9.78	9.38
payables turnover	17.22	3.41	404.80
inventory turnover	3.93	4.14	-5.05
roe	0.25	0.34	-26.95
capex per share	36.85	42.02	-12.32

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.25 on 2023-12-31 from 0.34 on 2022-12-31, representing a change of -26.95%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 18.05 on 2023-12-31 from 11.71 on 2022-12-31, representing a change of 54.13%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.40 on 2023-12-31 from 2.17 on 2022-12-31, representing a change of 10.46%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.28 on 2023-12-31 from 0.30 on 2022-12-31, representing a change of -8.04%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
2330.TW
calendar year	2024	2024	NaN
revenue per share	29.3	25.98	12.80
net income per share	12.54	9.56	31.24
operating cash flow per share	15.91	14.57	9.21
free cash flow per share	7.62	6.63	14.80
cash per share	83.6	79.01	5.82
book value per share	155.12	147.33	5.29
tangible book value per share	155.12	146.47	5.91
shareholders equity per share	154.01	146.22	5.33
interest debt per share	36.11	38.57	-6.39
market cap	24813096000000	25099244896000	-1.14
enterprise value	23862475000000	24297540158000	-1.79
pe ratio	19.07	25.32	-24.67
price to sales ratio	32.66	37.27	-12.36
pocfratio	60.16	66.46	-9.48
pfcf ratio	125.67	145.93	-13.88
pb ratio	6.21	6.62	-6.14
ptb ratio	6.21	6.62	-6.14
ev to sales	31.41	36.08	-12.93
enterprise value over ebitda	66.14	53.64	23.31
ev to operating cash flow	57.86	64.34	-10.07
ev to free cash flow	120.86	141.27	-14.45
earnings yield	0.01	0.01	32.75
free cash flow yield	0.01	0.01	16.12
debt to equity	0.23	0.26	-10.88
debt to assets	0.15	0.17	-8.93
net debt to ebitda	-2.64	-1.77	-48.89
current ratio	2.51	2.47	1.54
interest coverage	0	109.1	-100.00
income quality	1.27	1.52	-16.78
dividend yield	0.0	0.0	1.15
payout ratio	0.28	0.37	-23.80
sales general and administrative to revenue	0	0.03	-100.00
research and ddevelopement to revenue	0.07	0.07	-2.63
intangibles to total assets	0	0.0	-100.00
capex to operating cash flow	0.52	0.54	-4.28
capex to revenue	0.28	0.31	-7.32
capex to depreciation	1.28	1.25	2.63
stock based compensation to revenue	0	0.0	-100.00
graham number	208.49	177.34	17.57
roic	0.07	0.05	59.78
return on tangible assets	0.05	0.04	26.86
graham net net	13.8	6.95	98.55
working capital	1630050000000	1542742413001	5.66
tangible asset value	4021920000000	3797717606000	5.90
net current asset value	566710000000	429442284000	31.96
invested capital	4701649000000	4710546018001	-0.19
average receivables	230092209500	206134711500	11.62
average payables	135163705000	191555818000	-29.44
average inventory	282685293500	269806962999.5	4.77
days sales outstanding	29.61	28.09	5.43
days payables outstanding	19.9	55.24	-63.98
days of inventory on hand	82.28	75.45	9.06
receivables turnover	3.04	3.2	-5.15
payables turnover	4.52	1.63	177.63
inventory turnover	1.09	1.19	-8.31
roe	0.08	0.07	24.60
capex per share	8.29	7.93	4.54

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 19.07 on 2024-09-30 Q3 from 25.32 on 2024-06-30 Q2, representing a change of -24.67%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.51 on 2024-09-30 Q3 from 2.47 on 2024-06-30 Q2, representing a change of 1.54%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.23 on 2024-09-30 Q3 from 0.26 on 2024-06-30 Q2, representing a change of -10.88%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 415.04 which is lower than current price 1120, indicates the company may be overvalued.